Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid vs Kligman's formula for macular amyloidosis
IRCT20150529022468N5Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Macular Amyloidosis (2 arms), sponsored by Iran University of Medical Sciences. Started Nov 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20150529022468N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150529022468N5.